I hold a Master’s degree in Biotechnology from NTNU, where I focused on the interaction capabilities of microorganisms. I completed my PhD in Dr. Randi Syljuåsen's group at the Department of Radiation Biology, Institute for Cancer Research. My doctoral research investigated the interplay between the transcription machinery and cellular responses to replication stress and DNA damage.
In addition, I have experience working as an engineer at the Flow Cytometry Core Facility at the Institute for Cancer Research, a role I held for approximately six months.
My research interests are broad, spanning both basic and translational studies in DNA damage, immunology, and cancer biology.
In PRIMA, I focus on antibody engineering and the molecular interplay between antibodies and their cellular receptors. The goal is to develop IgGs with extended half-lives that efficiently target drivers of neurodegenerative diseases for TRIM21-mediated degradation.
Two obligatory questions!
1. What brought you to PRIMA?
I view PRIMA as an excellent opportunity to collaborate with individuals from diverse backgrounds, broadening my expertise and advancing my skills as a researcher. I am particularly fascinated by the potential of harnessing the body’s immune system to combat neurodegenerative diseases. I look forward to exploring this further by integrating it with advanced protein design in a highly specialized environment.
2. What are you passionate about?
I’m all about enjoying the outdoors – whether it’s hiking up a mountain, gliding through serene winter landscapes by cross-country skiing, or cruising along on my bike. When I’m indoors, you’ll often find me knitting or baking, or having spontaneous dance parties in the living room with my kids!